ARCHIVES

FDA Approves Two Oral Drugs For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

In Brief: Friedell To Head McDowell Network, New Kentucky Cancer Center; Nine Expiring Core Grants Approved

October 29, 1982

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

ARRA Funding Announcements Listed

April 10, 2009